Public and provider advocacy highlighted as FDA scrutinizes prescription fluoride
Strong fluoride formulations available by prescription, often utilized to avert dental caries in patients at elevated risk, are currently being evaluated by the U.S. Food and Drug Administration (FDA). Although dental experts have endorsed these products for many years, the FDA has initiated a re-assessment of these fluoride solutions because of intricacies related to their classification and approval process—sparking worries among healthcare professionals and supporters regarding the continued access to a vital resource in dental health maintenance.For many dental experts, prescription fluoride has long been a critical part of treatment for individuals vulnerable to cavities, including children, older adults, and…
